Congress of Neurological Surgeons Systematic Review and Evidence Based Guideline on Neuropathology for WHO Grade II Diffuse Glioma: Update

Overview

Journal J Neurooncol

Publisher Springer

Date 2025 Jan 3

PMID 39747718

Authors

Nataniel Mandelberg

Tiffany R Hodges

Tony J C Wang

Tresa McGranahan

Jeffrey J Olson

Daniel A Orringer

Affiliations

Soon will be listed here.

Abstract

Question: Does the addition of intraoperative optical histologic methods provide accuracy beyond the use of conventional histologic methods in diagnosis and management?

Recommendation: There is insufficient evidence at this time to suggest that intraoperative optical histologic methods offer increased diagnostic accuracy when compared to conventional techniques.

Target Population: Adult patients (age ≥ 18 years) who have suspected WHO grade II diffuse glioma.

New Recommendation: TARGET POPULATION: Adult patients (age ≥ 18 years) who have suspected WHO grade II diffuse glioma.

References

Cahill D, Sloan A, Nahed B, Aldape K, Louis D, Ryken T . The role of neuropathology in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline. J Neurooncol. 2015; 125(3):531-49. DOI: 10.1007/s11060-015-1909-8. View

Ohgaki H, Kleihues P . Epidemiology and etiology of gliomas. Acta Neuropathol. 2005; 109(1):93-108. DOI: 10.1007/s00401-005-0991-y. View

Rasmussen B, Hansen S, Laursen R, Kosteljanetz M, Schultz H, Norgard B . Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry. J Neurooncol. 2017; 135(3):571-579. DOI: 10.1007/s11060-017-2607-5. View

Ostrom Q, Bauchet L, Davis F, Deltour I, Fisher J, Langer C . The epidemiology of glioma in adults: a "state of the science" review. Neuro Oncol. 2014; 16(7):896-913. PMC: 4057143. DOI: 10.1093/neuonc/nou087. View

Ostrom Q, Price M, Neff C, Cioffi G, Waite K, Kruchko C . CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019. Neuro Oncol. 2022; 24(Suppl 5):v1-v95. PMC: 9533228. DOI: 10.1093/neuonc/noac202. View

Ostrom Q, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J . CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol. 2014; 16 Suppl 4:iv1-63. PMC: 4193675. DOI: 10.1093/neuonc/nou223. View

Barker 2nd F, Chang S, Huhn S, Davis R, Gutin P, McDermott M . Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer. 1997; 80(5):936-41. View

Burger P, Nelson J, Boyko O . Diagnostic synergy in radiology and surgical neuropathology: neuroimaging techniques and general interpretive guidelines. Arch Pathol Lab Med. 1998; 122(7):609-19. View

Kondziolka D, Lunsford L, Martinez A . Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg. 1993; 79(4):533-6. DOI: 10.3171/jns.1993.79.4.0533. View

10.

Wilden J, Kelly P . CT computerised stereotactic biopsy for low density CT lesions presenting with epilepsy. J Neurol Neurosurg Psychiatry. 1987; 50(10):1302-5. PMC: 1032455. DOI: 10.1136/jnnp.50.10.1302. View

11.

Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A . The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114(2):97-109. PMC: 1929165. DOI: 10.1007/s00401-007-0243-4. View

12.

Louis D, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee W . The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016; 131(6):803-20. DOI: 10.1007/s00401-016-1545-1. View

13.

Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A . Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol. 2009; 118(4):469-74. DOI: 10.1007/s00401-009-0561-9. View

14.

Tanaka K, Sasayama T, Mizukawa K, Takata K, Sulaiman N, Nishihara M . Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma. Clin Neurol Neurosurg. 2015; 138:37-44. DOI: 10.1016/j.clineuro.2015.07.019. View

15.

Jansen E, Hamisch C, Ruess D, Heiland D, Goldbrunner R, Ruge M . Observation after surgery for low grade glioma: long-term outcome in the light of the 2016 WHO classification. J Neurooncol. 2019; 145(3):501-507. DOI: 10.1007/s11060-019-03316-7. View

16.

Ghaffari-Rafi A, Samandouras G . Effect of Treatment Modalities on Progression-Free Survival and Overall Survival in Molecularly Subtyped World Health Organization Grade II Diffuse Gliomas: A Systematic Review. World Neurosurg. 2019; 133:366-380.e2. DOI: 10.1016/j.wneu.2019.08.111. View

17.

Coons S, Johnson P, Scheithauer B, Yates A, Pearl D . Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas. Cancer. 1997; 79(7):1381-93. DOI: 10.1002/(sici)1097-0142(19970401)79:7<1381::aid-cncr16>3.0.co;2-w. View

18.

Daumas-Duport C, Scheithauer B, OFallon J, Kelly P . Grading of astrocytomas. A simple and reproducible method. Cancer. 1988; 62(10):2152-65. DOI: 10.1002/1097-0142(19881115)62:10<2152::aid-cncr2820621015>3.0.co;2-t. View

19.

Eichberg D, Shah A, Di L, Semonche A, Jimsheleishvili G, Luther E . Stimulated Raman histology for rapid and accurate intraoperative diagnosis of CNS tumors: prospective blinded study. J Neurosurg. 2019; 134(1):137-143. DOI: 10.3171/2019.9.JNS192075. View

20.

Di L, Eichberg D, Huang K, Shah A, Jamshidi A, Luther E . Stimulated Raman Histology for Rapid Intraoperative Diagnosis of Gliomas. World Neurosurg. 2021; 150:e135-e143. DOI: 10.1016/j.wneu.2021.02.122. View